Liaoning Chengda Biotechnology (688739.SH) is expected to undergo a change in its controlling shareholder, and will be suspended from trading starting tomorrow.
Chengdu Xingrong Biological (688739.SH) announced that the company received a notice from its controlling shareholder Liaoning on February 10, 2025...
Liaoning Chengda Biotechnology (688739.SH) announced that on February 10, 2025, it received a notification from its controlling shareholder, Liaoning Cheng Da Co., Ltd., that they are planning for the board of directors' election related matters, which may result in a change in the company's actual controller. The company's stock will be suspended from trading starting from the morning of February 11, 2025 (Tuesday), and it is expected to resume trading within no more than 2 trading days.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


